390 related articles for article (PubMed ID: 16247522)
1. Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease.
Freeman HJ
Can J Gastroenterol; 2005 Oct; 19(10):603-6. PubMed ID: 16247522
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
[TBL] [Abstract][Full Text] [Related]
3. Erythema nodosum progressing to pyoderma gangrenosum as a complication of Crohn's disease.
Gellert A; Green ES; Beck ER; Ridley CM
Postgrad Med J; 1983 Dec; 59(698):791-3. PubMed ID: 6657543
[TBL] [Abstract][Full Text] [Related]
4. Concomitant occurrence of pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease.
Goldberg I; Finkel O; Gat A; Sprecher E; de Morentin HM
Isr Med Assoc J; 2014 Mar; 16(3):168-70. PubMed ID: 24761705
[TBL] [Abstract][Full Text] [Related]
5. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients.
Farhi D; Cosnes J; Zizi N; Chosidow O; Seksik P; Beaugerie L; Aractingi S; Khosrotehrani K
Medicine (Baltimore); 2008 Sep; 87(5):281-293. PubMed ID: 18794711
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
[TBL] [Abstract][Full Text] [Related]
7. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
Kujundzić M
Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
[TBL] [Abstract][Full Text] [Related]
8. [Erythema nodosum and Crohn's disease].
Areias E; García E Silva L
Med Cutan Ibero Lat Am; 1984; 12(6):489-95. PubMed ID: 6152299
[TBL] [Abstract][Full Text] [Related]
9. The effect of infliximab on extraintestinal manifestations of Crohn's disease.
Kaufman I; Caspi D; Yeshurun D; Dotan I; Yaron M; Elkayam O
Rheumatol Int; 2005 Aug; 25(6):406-10. PubMed ID: 15309501
[TBL] [Abstract][Full Text] [Related]
10. [Extraintestinal manifestations in Crohn's disease: risk factors and influence of intestinal surgery].
Nascimbeni R; Di Fabio F; Lanzini A; Lanzarotto F; Ricci C; Casella C; Salerni B
Ann Ital Chir; 2009; 80(4):293-8. PubMed ID: 19967888
[TBL] [Abstract][Full Text] [Related]
11. [Cutaneous symptoms of ulcero-haemorragic rectocolitis and of Crohn's disease (author's transl)].
Thivolet J; Ortonne JP; Jeune R
Ann Dermatol Venereol; 1978; 105(8-9):723-7. PubMed ID: 367248
[TBL] [Abstract][Full Text] [Related]
12. Erythema nodosum as an early sign of Crohn's disease.
van der Velden JJ; van Marion AM; Kremer B; Straetmans JM; Henquet CJ; Frank J
Int J Dermatol; 2007 Nov; 46 Suppl 3():27-9. PubMed ID: 17973885
[TBL] [Abstract][Full Text] [Related]
13. [Ulcerative colitis concomitant with pyoderma gangrenosum and erythema nodosum--presentation of two cases].
Wojas-Pelc A; Wielowieyska-Szybińska D; Setkowicz M; Szybiński P; Bogdaszewska-Czabanowska J
Przegl Lek; 2001; 58(10):945-9. PubMed ID: 11957826
[TBL] [Abstract][Full Text] [Related]
14. [Cutaneous manifestations in inflammatory bowel disease].
Chavez-Álvarez S; Gómez-Flores M; Ocampo-Candiani J
Gac Med Mex; 2016; 152(5):622-630. PubMed ID: 27792697
[TBL] [Abstract][Full Text] [Related]
15. How do I treat erythema nodosum, aphthous ulcerations, and pyoderma gangrenosum?
Hanauer SB
Inflamm Bowel Dis; 1998 Feb; 4(1):70; discussion 73. PubMed ID: 9552231
[No Abstract] [Full Text] [Related]
16. Treatment of pyoderma gangrenosum, erythema nodosum, and aphthous ulcerations.
Winter HS
Inflamm Bowel Dis; 1998 Feb; 4(1):71. PubMed ID: 9552232
[No Abstract] [Full Text] [Related]
17. Treatment of erythema nodosum, aphthous stomatitis, and pyoderma gangrenosum in patients with IBD.
Tremaine WJ
Inflamm Bowel Dis; 1998 Feb; 4(1):68-9; discussion 73. PubMed ID: 9552230
[No Abstract] [Full Text] [Related]
18. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease.
Ciccacci C; Biancone L; Di Fusco D; Ranieri M; Condino G; Giardina E; Onali S; Lepre T; Pallone F; Novelli G; Borgiani P
J Crohns Colitis; 2013 Feb; 7(1):44-52. PubMed ID: 22445837
[TBL] [Abstract][Full Text] [Related]
19. Peripheral arthritis in the course of inflammatory bowel diseases.
Yüksel I; Ataseven H; Başar O; Köklü S; Ertuğrul I; Ulker A; Dağlı U; Saşmaz N
Dig Dis Sci; 2011 Jan; 56(1):183-7. PubMed ID: 20458624
[TBL] [Abstract][Full Text] [Related]
20. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N
Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
